Why the McPherson's (ASX:MCP) share price could charge higher on Tuesday

The McPherson's Ltd (ASX:MCP) share price will be one to watch on Tuesday following an after market update today…

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The McPherson's Ltd (ASX: MCP) share price will be on watch on Tuesday following the release of a trading update after the market close.

What did McPherson's announce?

This afternoon McPherson's confirmed that sales from its core brands in the Australian market continue to exceed last year's figures.

According to the release, year to date, the company's owned brands, excluding the Dr. LeWinn's brand, have recorded sales growth of 7%.

This has been driven by double digit sales growth from the Manicare, Lady Jayne, and A'kin brands. Furthermore, market share growth has been recorded from 4 out of 6 of its owned brands.

The Dr. LeWinn's brand continues to weigh on the company's performance, though. Like A2 Milk Company Ltd (ASX: A2M), this has been caused by weakness in the daigou channel.

However, unlike a2 Milk, the sales of these products inside China haven't been strong, with Chinese Singles' Day sales falling well short of expectations.

Global Therapeutics acquisition.

In addition to this, the company revealed that the Global Therapeutics acquisition from Blackmores Limited (ASX: BKL) completed successfully on 30 November and its integration is progressing smoothly.

Management believes that this reflects the professional, collaborative approach of Global Therapeutics, McPherson's, and Blackmores.

McPherson's new Chief Executive Officer and Managing Director, Grant Peck, commented: "McPherson's year to date domestic sales growth reflects the consumer appeal of our market leading brands and our focus on new product innovation. All of the early signs are positive as we integrate Global Therapeutics into McPherson's and realise the complementary capabilities of the combined teams. Domestically, we continue to drive cashflow to support our mature dividend profile and modest debt levels."

Mr Peck, who was appointed CEO earlier this month after the sudden departure of Laurie McAllister following a series of terrible updates, also provided the market with guidance for the first half of FY 2021.

He revealed that McPherson's is on track to achieve its previous first half underlying profit before tax guidance in the range of $6.5 million to $7.5 million. This represents an 11.8% to 23.5% decline on the prior corresponding period's profit before tax of $8.5 million.

In addition to this, the new chief executive revealed that shareholders should expect a dividend March. He advised that the company's dividend policy is to pay a minimum dividend of 60% of underlying profit after tax, subject to cash requirements.

In line with this policy and based on its forecast first half underlying earnings, an interim fully franked dividend of at least 3 cents per share is expected to be paid to shareholders in March.

Annualised, this represents a fully franked 4.5% dividend yield. This may be far better than many had expected after its recent updates and guidance withdrawal.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia owns shares of and has recommended A2 Milk and Blackmores Limited. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Share Market News

Girl with painted hands.
Share Gainers

Here are the top 10 ASX 200 shares today

Investors were back to the races this Tuesday.

Read more »

A happy male investor turns around on his chair to look at a friend while a laptop runs on his desk showing share price movements
Broker Notes

Buy, hold, sell: Ventia, Sigma, and Mineral Resources shares

What is Ord Minnett saying about these shares?

Read more »

Businessman looks with one eye through magnifying glass.
Broker Notes

What is Morgans saying about Megaport and New Hope shares

Morgans has given its verdict on these shares after recent updates.

Read more »

Overjoyed man celebrating success with yes gesture after getting some good news on mobile.
Share Market News

4 ASX 200 shares tipped to jump another 50% to 60%

The ASX 200 Index is climbing higher this week, and it looks like these shares could keep going.

Read more »

Buy, hold, and sell ratings written on signs on a wooden pole.
Broker Notes

Up 29% since April, should you buy NextDC shares today?

A leading analyst digs into the outlook for NextDC’s rebounding shares.

Read more »

A man holds his hand under his chin as he concentrates on his laptop screen and reads about the ANZ share price
Broker Notes

Buy, hold, sell: Endeavour and these popular ASX shares

Let's see what analysts have to say about these shares this week.

Read more »

Smiling couple looking at a phone at a bargain opportunity.
Broker Notes

Why WiseTech shares are now looking like a bargain buy

A leading analyst forecasts better days ahead for WiseTech’s beaten-down shares.

Read more »

A woman with strawberry blonde hair has a huge smile on her face and fist pumps the air having seen good news on her phone.
Share Gainers

Why Elders, New Hope, Pro Medicus, and Tuas shares are storming higher today

These shares are having a strong session on Tuesday. Let's find out why.

Read more »